Downregulation of SLC22A1 mRNA expression in primary human HCC is in line with previously published microarray findings by Park et al., where SLC22A1 showed a significantly reduced expression in HCC [17]. This evidence concerns the gene SLC22A1 and hepatocellular carcinoma.